For more on this, see our guide to A Medical Guide to NAD+ Precursors: Understanding NR, NMN, and Your Cellular Health, and how it is evaluated and treated at Perfect B in Doral
We are not simply giving a shot
The published research literature has investigated: GHRH receptor activation in pituitary somatotroph cells Pulsatile release of endogenous growth hormone Subsequent IGF-1 elevation through downstream GH signaling Maintained natural feedback regulation through somatostatin and IGF-1 DPP-4-resistant pharmacokinetics from the trans-3-hexenoic acid modification The two compounds produce fundamentally different research effects: AOD-9604 produces lipolytic activity without affecting IGF-1 or broader GH-mediated signaling Tesamorelin produces full GH axis activation including IGF-1 elevation and broader GH-mediated effects Pharmacokinetic Comparison The compounds have different pharmacokinetic profiles: AOD-9604
At recommended dosages, Vitamin B-Complex Injection is well tolerated by most patients, but as with any parenteral therapy, side effects can occur
It supports healing it doesn't replace rest, rehab, sleep, and protein intake
The researchers concluded that AOD9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, zero serious adverse events were attributed to the peptide, and no participants withdrew due to treatment-related effects
